End-of-day quote
Egyptian Exchange
06:00:00 2024-05-06 pm EDT
|
5-day change
|
1st Jan Change
|
38
EGP
|
-0.03%
|
|
+1.41%
|
-4.21%
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
486.8
|
489.2
|
833.6
|
742.2
|
1,714
|
2,779
|
-
|
-
|
Enterprise Value (EV)
1 |
486.8
|
489.2
|
526.8
|
742.2
|
1,714
|
2,779
|
2,779
|
2,779
|
P/E ratio
|
-
|
7.69
x
|
6.26
x
|
3.51
x
|
3.14
x
|
4.53
x
|
4.11
x
|
3.94
x
|
Yield
|
13.4%
|
14.9%
|
8.77%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
1.34
x
|
1.73
x
|
1.35
x
|
1.97
x
|
2.73
x
|
2.26
x
|
2.11
x
|
EV / Revenue
|
-
|
1.34
x
|
1.73
x
|
1.35
x
|
1.97
x
|
2.73
x
|
2.26
x
|
2.11
x
|
EV / EBITDA
|
-
|
4,741,106
x
|
4,098,208
x
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
6,354,979
x
|
5,564,249
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
0.94
x
|
1.46
x
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
73,125
|
73,125
|
73,125
|
73,125
|
73,125
|
73,125
|
-
|
-
|
Reference price
2 |
6.658
|
6.690
|
11.40
|
10.15
|
23.44
|
38.00
|
38.00
|
38.00
|
Announcement Date
|
9/4/19
|
9/10/20
|
9/5/21
|
8/29/22
|
8/27/23
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
365.7
|
480.6
|
550.7
|
867.9
|
1,019
|
1,228
|
1,318
|
EBITDA
|
-
|
103.2
|
203.4
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
60.17
|
161.1
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
16.45%
|
33.52%
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
78.2
|
178.5
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
63.7
|
133.1
|
211
|
545.9
|
614
|
676
|
705
|
Net margin
|
-
|
17.42%
|
27.7%
|
38.32%
|
62.9%
|
60.26%
|
55.05%
|
53.49%
|
EPS
2 |
-
|
0.8700
|
1.820
|
2.890
|
7.470
|
8.390
|
9.240
|
9.650
|
Free Cash Flow
|
-
|
76.98
|
149.8
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
21.05%
|
31.17%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
74.6%
|
73.65%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
120.85%
|
112.55%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
0.8889
|
1.000
|
1.000
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/4/19
|
9/10/20
|
9/5/21
|
8/29/22
|
8/27/23
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
307
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
77
|
150
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
15.8%
|
12.6%
|
24.5%
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
10.8%
|
20.5%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
589.3
|
648.4
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
7.090
|
7.790
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
27.7
|
18.8
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
7.58%
|
3.9%
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/4/19
|
9/10/20
|
9/5/21
|
8/29/22
|
8/27/23
|
-
|
-
|
-
|
Average target price
47.8
EGP Spread / Average Target +25.79% Consensus |
1st Jan change
|
Capi.
|
---|
| -4.21% | 58.23M | | +5.70% | 104B | | -3.35% | 64.55B | | +46.67% | 41.5B | | +19.71% | 40.01B | | +6.70% | 33.03B | | +11.78% | 20.11B | | +17.06% | 17.52B | | +20.73% | 15.51B | | +11.69% | 15.34B |
Other Commodity Chemicals
|